4//SEC Filing
Abate Kristin 4
Accession 0001193125-25-241487
CIK 0001503802other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:33 PM ET
Size
4.9 KB
Accession
0001193125-25-241487
Insider Transaction Report
Form 4
Abate Kristin
Chief Accounting Officer
Transactions
- Award
Common Stock
2025-10-15+12,799→ 22,845 total
Footnotes (1)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as follows: 2,799 RSUs vest in two equal annual installments beginning October 31, 2026, and 10,000 RSUs vest 100% on October 15, 2026.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0002045943
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:33 PM ET
- Size
- 4.9 KB